The Ki67 cancer proliferation index is a validated prognostic factor in the evolution of breast cancer, being one of the surrogate elements in the establishment of the intrinsic type (luminal A, luminal B, HER2-positive, triple negative). This evidence concerns the gene MKI67 and breast carcinoma.